Developer docs
API playgroundTry for free, no card

Search company profiles

Bioagile Therapeutics

Full company profile

uuid002eosh

Namestring
Bioagile Therapeutics
Legal namestring
BioAgile Therapeutics Private Limited
Company typeenum
Private
Founded yearint
2015
Descriptiontext

BioAgile Therapeutics Private Limited is a privately-held, full-service Clinical Research Organization (CRO) headquartered in Bengaluru, India, operating from a CDSCO-approved and ISO 9001:2015-certified facility. The company delivers end-to-end clinical research services across the product lifecycle — preclinical (ADME, GLP toxicology, LC-MS/MS bioanalysis), Phase I-IV clinical trials, bioequivalence/bioavailability studies, regulatory support (CDSCO, FDA, EMA, ICH, eCTD), biostatistics, medical writing, clinical data management, and post-marketing surveillance — through a technology stack comprising ICH-GCP-aligned operations, 21 CFR Part 11-compliant eCRF, CTMS, electronic document management, and real-time project dashboards.

The company serves eight verticals — pharmaceuticals, nutraceuticals, cosmeceuticals, Software as a Medical Device (SaMD), FMCG, biotechnology, Ayurvedic and herbal products, and veterinary products — for enterprise sponsors including Wipro, Astellas Pharma, Amway, omniActive, Glanbia, MicroLabs, BD, Himalaya, and others across pharma, nutraceutical, and device categories. Specialized cosmeceutical instrumentation (TrichoScan, VapoMeter, ElastiMeter) supports skin and hair trials.

Revenue is generated through project-based, custom-quoted professional services contracts typically structured as multi-year engagements with onsite, offshore, or hybrid delivery. BioAgile markets a 30-40% cost advantage versus Western CROs while maintaining globally accepted regulatory deliverables. Leadership is concentrated in CEO Divya Chandradhara (biochemist, ex-Advinus Therapeutics and TATA Group); the company has no disclosed institutional investors, parent company, or M&A activity and operates as an independent entity.

Short descriptiontext

BioAgile Therapeutics is a Bengaluru-based, CDSCO-approved full-service CRO delivering preclinical through Phase IV clinical research, bioequivalence, and post-marketing surveillance for pharmaceutical, nutraceutical, cosmeceutical, SaMD, biotech, ayurvedic, and veterinary sponsors worldwide.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersBengaluru, India
HQ citystring
Bengaluru
HQ countrystring
India
HQ regionstring
Asia
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
clinical research services, contract research organization, clinical trial management, bioequivalence studies, preclinical research services
Industry4 codes
1Clinical CROs (Phase I–IV)
CodeHLAGAAAAPrimaryYes
2Preclinical CROs (Discovery/Pharmacology/DMPK)
CodeHLAGAAABPrimaryNo
3Clinical Data Management, Biostatistics & Statistical Programming CROs
CodeHLAGAAAFPrimaryNo
4Clinical Trial Informatics (EDC/CTMS/eCOA/eTMF)
CodeHLAGAJAMPrimaryNo
NAICS code2 codes
  • Scientific Research and Development Services5417
  • Research and Development in the Physical, Engineering, and Life Sciences54171
SIC code1 code
  • Services-Commercial Physical & Biological Research8731
Product category
Clinical Research Organization (CRO) Services
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Clinical Research Services
TypeProfessional Services
Description

Full-service CRO providing end-to-end clinical research solutions including clinical trials (Phase I-IV), preclinical services, BA/BE studies, regulatory support, biostatistics, medical writing, clinical data management, and post-marketing surveillance. Revenue generated through project-based contracts with pharmaceutical, nutraceutical, biotech, and medical device companies.

bioagiletherapeutics.com
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure
Pricing details1 tier
1Custom project-based pricing
ModelOtherBilling cadenceMulti-year contract
Notes

Quote-based / Not publicly disclosed. Pricing varies based on clinical trial phase (Phase I-IV), study complexity, therapeutic area, geographic scope, and service scope (full-service vs. modular).

bioagiletherapeutics.com
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

BioAgile Therapeutics is a full-service Clinical Research Organization (CRO) that delivers end-to-end clinical research solutions including Phase I-IV clinical trials, preclinical services, BA/BE bioequivalence studies, post-marketing surveillance, clinical data management, biostatistics, medical writing, and regulatory support. Services are offered across multiple verticals including pharmaceuticals, nutraceuticals, cosmeceuticals, SaMD, biotechnology, FMCG, ayurvedic/herbals, and veterinary products.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • Trusted by 100+ clients globally
+3 more records
Product overview1 text field

BioAgile Therapeutics is a full-service Clinical Research Organization (CRO) headquartered in Bangalore, India, offering an integrated platform of clinical research services. The portfolio is organized around four core service pillars: (1) Clinical Research Services encompassing clinical data management, clinical trials across all phases (I-IV), medical writing, quality assurance, efficacy evaluation, regulatory support, safety assessment, label claims substantiation, and biostatistics; (2) Preclinical Services covering ADME profiling, GLP toxicology, pharmacodynamics, and bioanalysis; (3) BA/BE Studies providing pharmacokinetic evaluations for bioequivalence; and (4) Post-Marketing Surveillance for ongoing product safety monitoring. These services are delivered across multiple industry verticals including pharmaceuticals, nutraceuticals, cosmeceuticals, SaMD (Software as a Medical Device), FMCG, Ayurvedic & Herbals, Biotechnology, and Veterinary. The company operates as a boutique CRO offering end-to-end services with an international reach, combining clinical trial management systems, electronic data management platforms, and regulatory submission tools (SUGAM portal, eCTD format) with ICH-GCP-aligned operations.

Product and service1 record
1Clinical Research Services
Scale indicator6 records

Each record includes

Type, Value, Description, Source

Partnership2 partners
Strategic tierNotableTypeStrategic or Co-development Partner
Description

Former employer affiliation of CEO Divya Chandradhara, with experience handling business for domestic and international markets. Represents professional background rather than active partnership.

Strategic tierNotableTypeStrategic or Co-development Partner
Description

Former employer affiliation of CEO Divya Chandradhara in the clinical and preclinical research industry. Represents professional background rather than active partnership.

Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Indian full-service CRO providing clinical research, BA/BE, bioanalytics, and clinical data management. Closely comparable in service mix and target sponsor base, especially for Phase I-III trials.

TypeDirect peer
Description

India-based CRO/CDMO spanning drug discovery, preclinical, and clinical services. Comparable as an India-headquartered mid-tier full-service research organization serving global pharma/biotech sponsors.

TypeDirect peer
Description

India-based CRO offering clinical research, bioanalytical, and dermatology/cosmeceutical testing. Direct overlap with BioAgile in cosmeceutical instrumental analysis and clinical dermatology services.

TypeBroad incumbent
Description

Global full-service CRO offering Phase I-IV, biostatistics, regulatory, and post-marketing services. Directly comparable service catalog; competes with BioAgile for India-outsourced clinical work.

TypeDirect peer
Description

India-headquartered integrated CRO/CDMO offering preclinical through clinical research services. Direct competitor for full-service clinical and preclinical study contracts from global pharma sponsors, with overlapping end-to-end delivery model.

TypeDirect peer
Description

India-based full-service CRO offering clinical trials, biostatistics, clinical data management, and regulatory services. Highly comparable peer in size, geography, and service offering.

TypeDirect peer
Description

India-based CRO offering clinical trials, BA/BE studies, and bioanalytical services. Direct peer in the same mid-tier Indian CRO segment targeting pharma and nutraceutical sponsors.

TypeDirect peer
Description

Mid-sized global CRO providing clinical research, regulatory, and biometrics services. Comparable as a mid-tier full-service CRO pursuing similar sponsor relationships.

TypeBroad incumbent
Description

Global CRO/CDMO with significant India operations offering preclinical through clinical services. Comparable integrated services model with established relationships with global pharma sponsors.

TypeBroad incumbent
Description

World's largest CRO with end-to-end clinical, technology, and data services. Establishes the global benchmark BioAgile competes against for large sponsor RFPs, and represents both a threat and a potential partnership counterpart.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers16 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment9 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile7 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature8 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Bioagile Therapeutics

Clinical Research Organization (CRO) Servicesbioagiletherapeutics.com

BioAgile Therapeutics is a Bengaluru-based, CDSCO-approved full-service CRO delivering preclinical through Phase IV clinical research, bioequivalence, and post-marketing surveillance for pharmaceutical, nutraceutical, cosmeceutical, SaMD, biotech, ayurvedic, and veterinary sponsors worldwide.

What Bioagile Therapeutics does

BioAgile Therapeutics Private Limited is a privately-held, full-service Clinical Research Organization (CRO) headquartered in Bengaluru, India, operating from a CDSCO-approved and ISO 9001:2015-certified facility. The company delivers end-to-end clinical research services across the product lifecycle — preclinical (ADME, GLP toxicology, LC-MS/MS bioanalysis), Phase I-IV clinical trials, bioequivalence/bioavailability studies, regulatory support (CDSCO, FDA, EMA, ICH, eCTD), biostatistics, medical writing, clinical data management, and post-marketing surveillance — through a technology stack comprising ICH-GCP-aligned operations, 21 CFR Part 11-compliant eCRF, CTMS, electronic document management, and real-time project dashboards.

The company serves eight verticals — pharmaceuticals, nutraceuticals, cosmeceuticals, Software as a Medical Device (SaMD), FMCG, biotechnology, Ayurvedic and herbal products, and veterinary products — for enterprise sponsors including Wipro, Astellas Pharma, Amway, omniActive, Glanbia, MicroLabs, BD, Himalaya, and others across pharma, nutraceutical, and device categories. Specialized cosmeceutical instrumentation (TrichoScan, VapoMeter, ElastiMeter) supports skin and hair trials.

Revenue is generated through project-based, custom-quoted professional services contracts typically structured as multi-year engagements with onsite, offshore, or hybrid delivery. BioAgile markets a 30-40% cost advantage versus Western CROs while maintaining globally accepted regulatory deliverables. Leadership is concentrated in CEO Divya Chandradhara (biochemist, ex-Advinus Therapeutics and TATA Group); the company has no disclosed institutional investors, parent company, or M&A activity and operates as an independent entity.

Bioagile Therapeutics firmographics

Firmographics
Name
Bioagile Therapeutics
Legal name
BioAgile Therapeutics Private Limited
Website
https://bioagiletherapeutics.com
Company type
Private
Founded year
2015
Operating status
Operating
Headcount range
1–10 employees
Short description
BioAgile Therapeutics is a Bengaluru-based, CDSCO-approved full-service CRO delivering preclinical through Phase IV clinical research, bioequivalence, and post-marketing surveillance for pharmaceutical, nutraceutical, cosmeceutical, SaMD, biotech, ayurvedic, and veterinary sponsors worldwide.
Ownership category
akta.pro rank

Bioagile Therapeutics industry classification

Industry
Product category
Clinical Research Organization (CRO) Services
NAICS
Scientific Research and Development Services (5417), Research and Development in the Physical, Engineering, and Life Sciences (54171)
SIC
Services-Commercial Physical & Biological Research (8731)
akta.pro primary industry
Clinical CROs (Phase I–IV) (HLAGAAAA)
akta.pro secondary industries
Preclinical CROs (Discovery/Pharmacology/DMPK) (HLAGAAAB), Clinical Data Management, Biostatistics & Statistical Programming CROs (HLAGAAAF), Clinical Trial Informatics (EDC/CTMS/eCOA/eTMF) (HLAGAJAM)

Keywords

  • Clinical research services
  • Contract research organization
  • Clinical trial management
  • Bioequivalence studies
  • Preclinical research services

Where Bioagile Therapeutics is headquartered

Location

Headquarters

HQ city
Bengaluru
HQ country
India
HQ region
Asia

Offices1 record

Markets served

Bioagile Therapeutics business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

  1. Clinical Research Services: Full-service CRO providing end-to-end clinical research solutions including clinical trials (Phase I-IV), preclinical services, BA/BE studies, regulatory support, biostatistics, medical writing, clinical data management, and post-marketing surveillance. Revenue generated through project-based contracts with pharmaceutical, nutraceutical, biotech, and medical device companies.

Pricing tiers

ModelBillingPrice
OtherMulti-year contractCustom project-based pricing

Go-to-market motion1 record

Distribution channels1 record

Marketing channels4 records

Bioagile Therapeutics product offering

Product offering

Core offering

BioAgile Therapeutics is a full-service Clinical Research Organization (CRO) that delivers end-to-end clinical research solutions including Phase I-IV clinical trials, preclinical services, BA/BE bioequivalence studies, post-marketing surveillance, clinical data management, biostatistics, medical writing, and regulatory support. Services are offered across multiple verticals including pharmaceuticals, nutraceuticals, cosmeceuticals, SaMD, biotechnology, FMCG, ayurvedic/herbals, and veterinary products.

Product overview

BioAgile Therapeutics is a full-service Clinical Research Organization (CRO) headquartered in Bangalore, India, offering an integrated platform of clinical research services. The portfolio is organized around four core service pillars: (1) Clinical Research Services encompassing clinical data management, clinical trials across all phases (I-IV), medical writing, quality assurance, efficacy evaluation, regulatory support, safety assessment, label claims substantiation, and biostatistics; (2) Preclinical Services covering ADME profiling, GLP toxicology, pharmacodynamics, and bioanalysis; (3) BA/BE Studies providing pharmacokinetic evaluations for bioequivalence; and (4) Post-Marketing Surveillance for ongoing product safety monitoring. These services are delivered across multiple industry verticals including pharmaceuticals, nutraceuticals, cosmeceuticals, SaMD (Software as a Medical Device), FMCG, Ayurvedic & Herbals, Biotechnology, and Veterinary. The company operates as a boutique CRO offering end-to-end services with an international reach, combining clinical trial management systems, electronic data management platforms, and regulatory submission tools (SUGAM portal, eCTD format) with ICH-GCP-aligned operations.

Differentiator

Problem solved

Functional benefit

Products and services

  • Clinical Research Services

Quantifiable outcome

  • Trusted by 100+ clients globally
  • +3 more outcomes

Companies that use Bioagile Therapeutics

Customer profile

Named customers16 records

Segments9 records

Ideal customer profiles7 records

Bioagile Therapeutics technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature8 records

Bioagile Therapeutics partnerships and signals

Strategic signal

Partnerships

Two partnerships are on record, tiered notable.

  • Advinus TherapeuticsnotableStrategic or Co-development PartnerFormer employer affiliation of CEO Divya Chandradhara, with experience handling business for domestic and international markets. Represents professional background rather than active partnership.
  • TATA GroupnotableStrategic or Co-development PartnerFormer employer affiliation of CEO Divya Chandradhara in the clinical and preclinical research industry. Represents professional background rather than active partnership.

Scale indicators6 records

Recent moves5 records

Expansion highlights5 records

Bioagile Therapeutics competitors and assessment

Company assessment

Direct peers

  • Lambda Therapeutic Research: Indian full-service CRO providing clinical research, BA/BE, bioanalytics, and clinical data management. Closely comparable in service mix and target sponsor base, especially for Phase I-III trials.
  • Sai Life Sciences: India-based CRO/CDMO spanning drug discovery, preclinical, and clinical services. Comparable as an India-headquartered mid-tier full-service research organization serving global pharma/biotech sponsors.
  • Cliantha Research: India-based CRO offering clinical research, bioanalytical, and dermatology/cosmeceutical testing. Direct overlap with BioAgile in cosmeceutical instrumental analysis and clinical dermatology services.
  • Syngene International: India-headquartered integrated CRO/CDMO offering preclinical through clinical research services. Direct competitor for full-service clinical and preclinical study contracts from global pharma sponsors, with overlapping end-to-end delivery model.
  • Siro Clinpharm: India-based full-service CRO offering clinical trials, biostatistics, clinical data management, and regulatory services. Highly comparable peer in size, geography, and service offering.
  • Veeda Clinical Research: India-based CRO offering clinical trials, BA/BE studies, and bioanalytical services. Direct peer in the same mid-tier Indian CRO segment targeting pharma and nutraceutical sponsors.
  • Clinipace Worldwide: Mid-sized global CRO providing clinical research, regulatory, and biometrics services. Comparable as a mid-tier full-service CRO pursuing similar sponsor relationships.

Broad incumbents

  • Parexel International: Global full-service CRO offering Phase I-IV, biostatistics, regulatory, and post-marketing services. Directly comparable service catalog; competes with BioAgile for India-outsourced clinical work.
  • Pharmaron: Global CRO/CDMO with significant India operations offering preclinical through clinical services. Comparable integrated services model with established relationships with global pharma sponsors.
  • IQVIA: World's largest CRO with end-to-end clinical, technology, and data services. Establishes the global benchmark BioAgile competes against for large sponsor RFPs, and represents both a threat and a potential partnership counterpart.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

Bioagile Therapeutics social profiles

Digital presence

Bioagile Therapeutics financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Bioagile Therapeutics leadership team

Management profile

Number of profiles

Profiles1 record

Bioagile Therapeutics funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Bioagile Therapeutics M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Bioagile Therapeutics

What does Bioagile Therapeutics do?

BioAgile Therapeutics is a full-service Clinical Research Organization (CRO) that delivers end-to-end clinical research solutions including Phase I-IV clinical trials, preclinical services, BA/BE bioequivalence studies, post-marketing surveillance, clinical data management, biostatistics, medical writing, and regulatory support. Services are offered across multiple verticals including pharmaceuticals, nutraceuticals, cosmeceuticals, SaMD, biotechnology, FMCG, ayurvedic/herbals, and veterinary products.

Is Bioagile Therapeutics a public or private company?

Bioagile Therapeutics is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Bioagile Therapeutics founded?

Bioagile Therapeutics was founded in 2015. It employs 1 to 10 people.

Where is Bioagile Therapeutics based?

Bioagile Therapeutics is headquartered in Bengaluru, India, in the Asia region.

How does Bioagile Therapeutics make money?

One revenue line is on record: clinical Research Services.

Who are Bioagile Therapeutics's main competitors?

Direct peers on record are Lambda Therapeutic Research, Sai Life Sciences, Cliantha Research, Syngene International, Siro Clinpharm, Veeda Clinical Research and Clinipace Worldwide. Broad incumbents are Parexel International, Pharmaron and IQVIA.

Does Bioagile Therapeutics have an API?

No public API is recorded for Bioagile Therapeutics.

What industry is Bioagile Therapeutics in?

Bioagile Therapeutics's product category is Clinical Research Organization (CRO) Services. Its primary akta.pro industry code is HLAGAAAA, Clinical CROs (Phase I–IV), with a secondary code of HLAGAAAB, Preclinical CROs (Discovery/Pharmacology/DMPK). Its NAICS code is 5417 and its SIC code is 8731.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales